Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Comment by JAKPUG4LIFEon May 15, 2020 3:44pm
10 Views
Post# 31035539

RE:RE:RE:RE:Palmitoylethanolamide

RE:RE:RE:RE:Palmitoylethanolamide.02 cents after an unheard of 201/1 split. Mostly retailer ownership where most will need over $100 share price to break even. Look at financials, I think insiders are doing just fine even though share price is at 2cents.. Assets being sold off to stay alive. Making double current loss, make that well over $200 to make any. EDUCATE YOURSELF
Mil_Man54 wrote: You pumper tactics still apply.  Just educatng investors about what's happening on th is board

Milman69 wrote:
FSD Pharma is not a penny stock it is above $1.

Thanks it's outstanding share stucture is tight with alot of insider ownership.

Skies the limit insiders don't invest into losing companies.

Mil_man54 is a professional basher troll he comes here everyday to talk bad about FSD.

I will laugh at him so hard when all his assumptions become untrue.

Time will tell shareholders those that sold sorry for your loss , those that didn't sell I hope you make double then your current loss.

Cheers




Bullboard Posts